The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response

  • Received : 2016.12.13
  • Accepted : 2017.02.03
  • Published : 2017.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Atopic dermatitis (AD) is an inflammatory skin condition accompanied by symptoms such as edema and hemorrhage. Kimchi is a traditional fermented Korean dish consisting of various probiotics. In this study, the therapeutic effect of Lactobacillus plantarum CJLP55 isolated from Kimchi was studied in AD-induced mice. Orally administered Lactobacillus strain, CJLP55, suppressed AD symptoms and high serum IgE levels. CJLP55 administration reduced the thickness of the epidermis, infiltration of mast cells and eosinophils into the skin lesion, enlargement of axillary lymph nodes, and increase in cell population in axillary lymph nodes. CJLP55 treatment decreased the production of type 2 cytokines, such as interleukin (IL)-4, IL-5, IL-10, IL-12, interferon (IFN)-${\gamma}$, and IL-6,which were stimulated by house dust mite extracts, in the axillary lymph node cells. Orally administered CJLP55 exhibited a therapeutic effect on house dust mite-induced AD in NC/Nga mice after onset of the disease by altering immune cell activation. The Lactobacillus strain, CJLP55, isolated from Kimchi, suppressed AD. Our results suggest its possible use as a potential candidate for management of AD.

Keywords

References

  1. Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22:125-137. https://doi.org/10.5021/ad.2010.22.2.125
  2. Ogg G. Role of T cells in the pathogenesis of atopic dermatitis. Clin Exp Allergy. 2009;39:310-316. https://doi.org/10.1111/j.1365-2222.2008.03146.x
  3. Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, Avershina E, Rudi K, Narbad A, Jenmalm MC, Marchesi JR, Collado MC. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015;26:26050.
  4. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy. 2015;45:43-53. https://doi.org/10.1111/cea.12332
  5. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B6, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-514. https://doi.org/10.1038/nrgastro.2014.66
  6. Schiavi E, Barletta B, Butteroni C, Corinti S, Boirivant M, Di Felice G. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy. 2011;66:499-508. https://doi.org/10.1111/j.1398-9995.2010.02501.x
  7. Matsuzaki T, Takagi A, Ikemura H, Matsuguchi T, Yokokura T. Intestinal microflora: probiotics and autoimmunity. J Nutr. 2007;137(3 Suppl 2):798S-802S. https://doi.org/10.1093/jn/137.3.798S
  8. Won TJ, Kim B, Song DS, Lim YT, Oh ES, Lee DI, Park ES, Min H, Park SY, Hwang KW. Modulation of Th1/Th2 balance by Lactobacillus strains isolated from Kimchi via stimulation of macrophage cell line J774A.1 in vitro. J Food Sci. 2011;76:H55-61. https://doi.org/10.1111/j.1750-3841.2010.02031.x
  9. Won TJ, Kim B, Lim YT, Song DS, Park SY, Park ES, Lee DI, Hwang KW. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice. J Appl Microbiol. 2011;110:1195-1202. https://doi.org/10.1111/j.1365-2672.2011.04981.x
  10. Yang G, Liu ZQ, Yang PC. Treatment of allergic rhinitis with probiotics: an alternative approach. N Am J Med Sci. 2013;5:465-468. https://doi.org/10.4103/1947-2714.117299
  11. Matricardi PM, Bjorksten B, Bonini S, Bousquet J, Djukanovic R, Dreborg S, Gereda J, Malling HJ, Popov T, Raz E, Renz H, Wold A; EAACI Task Force 7. Microbial products in allergy prevention and therapy. Allergy. 2003;58:461-471. https://doi.org/10.1034/j.1398-9995.2003.00175.x
  12. Prescott SL, Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol. 2007;120:255-262. https://doi.org/10.1016/j.jaci.2007.04.027
  13. Segawa S, Hayashi A, Nakakita Y, Kaneda H, Watari J, Yasui H. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biol Pharm Bull. 2008;31:884-889. https://doi.org/10.1248/bpb.31.884
  14. Tobita K, Yanaka H, Otani H. Heat-treated Lactobacillus crispatus KT strains reduce allergic symptoms in mice. J Agric Food Chem. 2009;57:5586-5590. https://doi.org/10.1021/jf900703q
  15. Sunada Y, Nakamura S, Kamei C. Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol. 2008;8:1761-1766. https://doi.org/10.1016/j.intimp.2008.08.011
  16. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 1997;9:461-466. https://doi.org/10.1093/intimm/9.3.461
  17. Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol. 2011;41:298-310. https://doi.org/10.1007/s12016-011-8252-4
  18. Lim HS, Ha H, Lee MY, Jin SE, Jeong SJ, Jeon WY, Shin NR, Sok DE, Shin HK. Saussurea lappa alleviates inflammatory chemokine production in HaCaT cells and house dust mite-induced atopic-like dermatitis in Nc/Nga mice. Food Chem Toxicol. 2014;63:212-220. https://doi.org/10.1016/j.fct.2013.10.050
  19. Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H, Ishii A. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy. 2003;58:139-145. https://doi.org/10.1034/j.1398-9995.2003.23790.x
  20. Yamamoto M, Haruna T, Yasui K, Takahashi H, Iduhara M, Takaki S, Deguchi M, Arimura A. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Int. 2007;56:139-148. https://doi.org/10.2332/allergolint.O-06-458
  21. Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, Nakanishi K, Yamanishi K. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitislike inflammation in mice. Proc Natl Acad Sci U S A. 2013;110:13921-13926. https://doi.org/10.1073/pnas.1307321110
  22. Staumont-Salle D, Fleury S, Lazzari A, Molendi-Coste O, Hornez N, Lavogiez C, Kanda A, Wartelle J, Fries A, Pennino D, Mionnet C, Prawitt J, Bouchaert E, Delaporte E, Glaichenhaus N, Staels B, Julia V, Dombrowicz D. $CX_3CL1$ (fractalkine) and its receptor $CX_3CR1$ regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med. 2014;211:1185-1196. https://doi.org/10.1084/jem.20121350
  23. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis--eosinophil granule proteins as markers of disease activity. Allergy. 1993;48:1-5.
  24. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59:561-570. https://doi.org/10.1111/j.1398-9995.2004.00476.x
  25. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest. 2003;112:1058-1066. https://doi.org/10.1172/JCI18246
  26. Fishman MA, Perelson AS. Th1/Th2 differentiation and crossregulation. Bull Math Biol. 1999;61:403-436. https://doi.org/10.1006/bulm.1998.0074
  27. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998;19:359-361. https://doi.org/10.1016/S0167-5699(98)01285-7
  28. Toshitani A, Ansel JC, Chan SC, Li SH, Hanifin JM. Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol. 1993;100:299-304. https://doi.org/10.1111/1523-1747.ep12469875
  29. Gharagozlou M, Farhadi E, Khaledi M, Behniafard N, Sotoudeh S, Salari R, Darabi B, Fathi SM, Mahmoudi M, Aghamohammadi A, Amirzargar AA, Rezaei N. Association between the interleukin 6 genotype at position -174 and atopic dermatitis. J Investig Allergol Clin Immunol. 2013;23:89-93.
  30. Kataria J, Li N, Wynn JL, Neu J. Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev. 2009;67:546-550. https://doi.org/10.1111/j.1753-4887.2009.00226.x

Cited by

  1. Tabetri™ ( Tabebuia avellanedae Ethanol Extract) Ameliorates Atopic Dermatitis Symptoms in Mice vol.2018, pp.None, 2017, https://doi.org/10.1155/2018/9079527